Publications

5808 Results

SWOG 1318: Combination of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: Longer Follow up and Predictors of Outcomes

Authors
A Advani;A Moseley;K O'Dwyer;C Yeung;O Sala-Torra;B Wood;J Park;M Wieduwilt;D Jeyakumar;G Yaghmour;E Atallah;A Gerds;S O'Brien;J Liesveld;M Othus;M Litzow;R Stone;J Radich;H Erba
Journal / Conference
ASH Annual Meeting (December 6-9, 2025, Orlando, FL). Abstract 3343 poster. Blood (2025) 146 (Supplement 1): 3343
Year
2025
Research Committee(s)
Leukemia
Study Number(s)
S1318

Development and Validation of a Gene Expression Signature to Predict Early Events in Patients with Follicular Lymphoma

Authors
C Ramsower;G Wright;H Li;J Cerhan;M Mauer;R Mwangi;A Rosenthal;A Novak;B Link;T Witzig;T Habermann;R Kridel;M LeBlanc;M Shadman;S Smith;J Friedberg;D Scott;C Steidl;L Staudt;L Rimsza
Journal / Conference
Blood Advances 2025 Dec 23;9(24):6443-6454. doi: 10.1182/bloodadvances.2025016827.
Year
2025
Research Committee(s)
Lymphoma
PMID
40966421
PMC
PMC12755980
Study Number(s)
S0016

Clinical Trial of Docetaxel with Androgen Receptor Pathway Inhibitors for Metastatic Castration-Sensitive Prostate Cancer Patients with a Suboptimal PSA Response

Authors
A Sokolova;M Ong;S Hotte;T Dorff;K Chi;A Wyatt;A Goldkorn;M Kolinsky;M Brundage;A Ndika;S Lerner;W Parulekar;K Ding;M Jafri
Journal / Conference
Prostate Cancer Foundation annual meeting (October 23-25, 2025, Carlsbad, CA)
Year
2025
Research Committee(s)
Genitourinary
Study Number(s)
CCTG-PR26

Breastfeeding after hormone-receptor positive breast cancer: results from the POSITIVE trial

Authors
F Peccatori
Journal / Conference
Journal of Clinical Oncology, 2025 Aug 20;43(24):2712-2719. doi: 10.1200/JCO-24-02697. Epub 2025 Jul 9.
Year
2025
Research Committee(s)
Cancer Survivorship
PMID
40632989
Study Number(s)
CTSU/A221405

Development and Validation of a Risk Prediction Model for Acute Care Use Among Older Patients with Advanced Cancer on Clinical Trials

Authors
D Hershman;C Till;M LeBlanc;S Ramsey;J Unger
Journal / Conference
JNCI djaf342; publ Dec 4, 2025; 10.1093/jnci/djaf342
Year
2025
Research Committee(s)
Cancer Care Delivery

Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage Cancer: SWOG S1714

Authors
M Trivedi;J Unger;NL Henry;A Darke;D Hertz;T Brannagan;S Reyes;B Schneider;W Irvin;A Hathaway;A Vander Woude;V Gudena;P Cabrera-Galeana;M Orsted;M LeBlanc;M Fisch;D Hershman
Journal / Conference
JAMA Network Open. 2026 Apr 1;9(4):e264901. doi: 10.1001/jamanetworkopen.2026.4901.
Year
2025
Research Committee(s)
Symptom Management and Survivorship
PMID
41961500
PMC
PMC13069458
Study Number(s)
S1714

Neoadjuvant PD-1 blockade in patients with surgically resectable desmoplastic 3 melanoma (SWOG S1512 cohort A)

Authors
K Kendra;S Bellasea;Z Eroglu;S Hu-Lieskovan;K Campbell;W Carson;D Wada;J Plaza;G In;A Ikeguchi;J Hyngstrom;A Brohl;B Chmielowski;N Khushalani;J Markowitz;M Monroe;C Contreras;E Medina;C Gonzalez;I Baselga Carretero;I Perez Garcilazo;A Vega-Crespo;J Ming Chen;N Naser Al Deen;S Patel;K Grossmann;V Sondak;E Sharon;J Moon;M Wu;A Ribas
Journal / Conference
Nature Cancer. 2026 Feb;7(2):272-282. doi: 10.1038/s43018-025-01113-y. Epub 2026 Jan 29.
Year
2025
Research Committee(s)
Melanoma
PMID
41611998
PMC
PMC12948668
Study Number(s)
S1512

Bone biomarkers and subsequent survival in men with hormone sensitive prostate cancer: results from the SWOG S1216 phase III trial of androgen deprivation therapy with or without orteronel

Authors
P Lara;E Mayerson;E Gertz;C Tangen;A Goldkorn;M Van Loan;M Hussain;S Gupta;J Zhang;M Parikh;P Twardowski;D Quinn;N Vogelzang;I Thompson;N Agarwal
Journal / Conference
European Urology Feb;85(2):171-176
Year
2024
Research Committee(s)
Genitourinary
PMID
PMID37085425
PMC
PMC10662935
Study Number(s)
S1216

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

Authors
G Garcia-Manero;N Podoltsev;M Othus;J Pagel;J Radich;M Fang;D Rizzieri;G Marcucci;SA Strickland;MR Litzow;M Savoie;B Medeiros;M Sekeres;TL Lin;G Uy;BL Powell;JE Kolitz;RA Larson;RM Stone;D Claxton;J Essell;S Luger;S Mohan;A Moseley;F Appelbaum;HP Erba
Journal / Conference
Leukemia Jan;38(1):58-66
Year
2024
Research Committee(s)
Leukemia
PMID
PMID37935977
Study Number(s)
S1203

Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Authors
S Lerner;D McConkey;C Tangen;JJ Meeks;T Flaig;X Hua;S Daneshmand;A Alva;MS Lucia;D Theodorescu;A Goldkorn;M Milowsky;W Choi;R Bangs;D Gustafson;M Plets;IM Thompson
Journal / Conference
Clinical Cancer Research Jan 17;30(2):444-449
Year
2024
Research Committee(s)
Genitourinary
PMID
PMID37966367
PMC
PMC10824507
Study Number(s)
S1314